Login to Your Account

Pfizer to develop, sell antifungal treatment in Asia via Basilea deal

By David Ho
Staff Writer

Wednesday, December 6, 2017

HONG KONG – Pfizer Inc. will bring Basilea Pharmaceutica Ltd.'s novel antifungal medicine to China and other major Asian markets as it works to meet a significant unmet need, one that is a leading cause of death across Asia.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription